Were Fat Studies Buried? The Data They Never Published | Mark Hyman
Mark Hyman discusses the Minnesota Coronary Experiment by Ansel Keys, examining whether it was buried or simply incomplete due to methodological flaws. Despite high dropout rates and control issues in that study, he notes that meta-analyses of higher-quality, longer-duration trials without trans fat confounding variables do show reduced cardiovascular disease risk.
Summary
The transcript discusses the Minnesota Coronary Experiment, an Ansel Keys study that has been subject to debate regarding whether its results were deliberately buried or if the study was simply incomplete and underpowered for publication. The speaker notes that 75% of subjects dropped out in the first year, which may have led the research team to question whether they had sufficient statistical power to detect meaningful differences or publish significant findings. The study was conducted in a psychiatric ward setting with a randomized design where participants were unaware of their fat source—receiving either saturated fats or margarine in a cafeteria setting. Additional control issues included participants being allowed to leave for multiple days at home before returning, which introduced confounding variables by modern standards. The speaker acknowledges that when examining meta-analyses of studies with longer duration, lower dropout rates, and better intervention design that avoids trans fat confounding variables, there is evidence of reduced cardiovascular event risk. The speaker emphasizes that meta-analysis quality depends heavily on the quality of included studies.
Key Insights
- The Minnesota Coronary Experiment had a 75% dropout rate in the first year, which may have made researchers question whether they had sufficient statistical power to detect significant findings or justify publication
- The study was conducted in a psychiatric ward where participants could leave and stay home for multiple days before returning, creating control problems that would be considered inadequate by modern research standards
- Debate exists over whether the Minnesota Coronary Experiment was deliberately buried or simply remained unpublished due to being incomplete and underpowered
- Meta-analyses of longer-duration trials with lower dropout rates and proper intervention design that exclude trans fat confounding show evidence of reduced cardiovascular event risk
- The quality of meta-analysis conclusions depends heavily on the quality of the individual studies included in the analysis
Topics
Transcript
[0:00] Minnesota Coronary Experiment. And that was an Ansel Keys study. And there are some different opposing views on that, whether it was buried or whether it was incomplete. 75% of the subjects appear to dropped out in the first year. So, it may well have been that the research team were like, "This is completely underpowered for us to even publish and understand like do we have a significant finding here or do we have enough power to detect a difference?" This was in the setting of a psychiatric ward. So, the way they had it set up, it was randomized. People didn't know what fat they were getting. So, when they make the food in the kind of…
Full transcript available for MurmurCast members
Sign Up to AccessMore from The Proof with Simon Hill
MASH vs. MASLD: Which Medications Are Actually FDA Approved for Weight Loss? | Dr Mauricio Gonzalez
Dr. Mauricio Gonzalez clarifies that the United States has two FDA-approved medications specifically for MASH (metabolic dysfunction-associated steatohepatitis): resmetirom and semaglutide (Wegovy). However, for pure MASLD (metabolic dysfunction-associated fatty liver disease) without inflammation, there are currently no FDA-approved medications.
How Effective Are Weight Loss Drugs? The Risk and Limitations You Should Know About | EP#422
GLP-1 weight loss drugs are significantly more effective than diet alone, with 90-95% of clinical trial participants losing weight, but real-world non-response rates reach 20%. However, discontinuation rates are high (75% within 18 months), and without proper nutrition and exercise support, users risk losing up to 40% muscle mass while regaining primarily fat, creating sarcopenic obesity.
What Is the MIND Diet? (You Don't Have to Eat Perfectly) | Dr Terry Simpson
The MIND diet combines Mediterranean and DASH diets, focusing on increased fruits, vegetables, legumes, whole grains, and healthy fats while reducing red meat. Dr. Simpson emphasizes that perfection isn't required—studies show people scoring around 12.5 out of 15 points experienced the most benefits.
How Does HeartFlow's AI Analyze Your Heart Scan? | Dr Campbell Rogers | EP#426
Dr. Campbell Rogers explains HeartFlow's AI analysis process for heart scans, emphasizing that the company assesses image quality first, rejecting approximately 2-3% of scans that are too fuzzy. He highlights that scanner type, procedure techniques, and medications used at each site significantly impact image quality and the ability to track disease progression over time.
Muscle Loss Fix: Why Movement Beats More Protein | Simon Hill
Protein is often overemphasized in discussions about muscle loss, but the real driver of sarcopenia in America is sedentary lifestyle and lack of resistance training stimulus. Most people consume sufficient protein; the limiting factor is movement and strength training, not dietary protein intake.